Vielanin P enhances the cytotoxicity of doxorubicin via the inhibition of PI3K/Nrf2-stimulated MRP1 expression in MCF-7 and K562 DOX-resistant cell lines

Gao, HL; Xia, YZ; Zhang, YL; Yang, L; Kong, LY

Yang, L; Kong, LY (reprint author), China Pharmaceut Univ, Jiangsu Key Lab Bioact Nat Prod Res, 24 Tong Jia Xiang, Nanjing 210009, Jiangsu, Peoples R China.

PHYTOMEDICINE, 2019; 58 ():

Abstract

Background: Cancer cells that are resistant to structurally and mechanically unrelated anticancer drugs are said to have multidrug resistance (MDR). T......

Full Text Link